ReviewBJR artificial intelligence2026
Casting wider than U-Nets: evaluating the role of novel machine learning applications in radiation therapy.
Review in BJR artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiation oncology has proven an early adopter of machine learning (ML) and deep learning (DL) owing to its image-centered workflow and data richness. DL auto-segmentation of normal structures is already guideline-endorsed, with self-configuring nnU-Net delivering near-state-of-the-art accuracy and widely adopted. In this review, we explore advances in ML algorithms in processing and interpreting imaging-based data beyond normal tissue auto-segmentation with applications upstream and downstream of this task, highlighting training data volume and best-in-class architectures. Applications discussed range from diagnostics with "virtual biopsies" and automated staging to radiotherapy planning with gross tumor volume and clinical target volume (CTV) prediction. We illustrate the developments of cutting-edge transformer-based designs and foundation models, but also the important role of lightweight, task-specific classical ML models. Data scarcity may be eased by developments in few-shot learning (FSL) and transfer learning strategies. We also consider how end-to-end automated CTV delineation may require an agentic approach to mimic the reasoning of a radiation oncologist, capable of processing multi-modal data with clinical context. Together, these advancements point toward a future where ML will become increasingly central to radiation oncology practice. However, implementation of these tools beyond normal tissue auto-segmentation remains limited and will require careful assessment and validation in the clinic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.